We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

Enzyme Could Provide Biofuel Boost

News

Researchers at Tokyo Institute of Technology have honed in on an enzyme belonging to the glycerol-3-phosphate acyltransferase (GPAT) family as a promising target for increasing biofuel production from the red alga Cyanidioschyzon merolae.

READ MORE

Blood Test Could Identify Women at Risk for Gestational Diabetes

News

Early screening could allow for lifestyle changes before gestational diabetes develops.

READ MORE

Autism Linked to Egg Cells' Difficulty Creating Large Proteins

News

Genetic factors underlying fragile X syndrome, and potentially from other autism-related disorders, stem from defects in the cell's ability to create unusually large protein structures

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE